Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies
Clinical trial NCT03403036 · COMPLETED
Trial details
- NCT number
- NCT03403036
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-31
- Primary completion
- 2018-08-18
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.